US5800541A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Collagen-synthetic polymer matrices prepared using a multiple step reaction
Assignee: Surgical Specialties US Corp
•
Filing: 1997-01-08
•
Granted: 1998-09-01
•
Expires: 2017-01-08
Abstract
Abstract The present invention discloses collagen-synthetic polymer matrices which are prepared using a multiple step reaction. The first step of the reaction generally involves reacting collagen with a functionally activated synthetic hydrophilic polymer to form a collagen-synthetic polymer matrix. The synthetic hydrophilic polymer may be mono- or multifunctionally activated, but is preferably difunctionally activated, resulting in the formation of a crosslinked collagen matrix. The second step comprises modifying the collagen-synthetic polymer matrix according to one or more of the following methods: further crosslinking the matrix using a multifunctionally activated synthetic polymer, conjugating the matrix using a monofunctionally activated synthetic polymer, coupling biologically active molecules or glycosaminoglycans to the matrix, crosslinking the matrix using conventional chemical crosslinking agents, or modifying the collagen in the matrix by means of various chemical reactions. An optional third step may include further modification of the collagen-synthetic polymer matrix by covalently binding, for example, biologically active molecules or glycosaminoglycans to the matrix by means of available active groups on the synthetic hydrophilic polymers. Collagen-synthetic polymer matrices prepared according to the methods of the present invention have very low immunogenicity and can therefore be used to prepare biocompatible implants for use in a variety of medical applications.
Inventors
- 👤 Woonza M. Rhee
- 👤 Richard A. Berg
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 20:03
CPC Classifications
C; C08; C08L; C08L89/00; C08L89/04; C08L89/06; A; A61; A61L; A61L24/00; A61L24/04; A61L24/10; A61L24/102; A61L27/00; A61L27/14; A61L27/22; A61L27/24; A61L27/26; A61L27/28; A61L27/34; A61L27/40; A61L27/44; A61L27/50; A61L27/54; A61L31/00; A61L31/04; A61L31/041; A61L31/043; A61L31/044; A61L31/08; A61L31/10; A61L31/12; A61L31/125; A61L31/14; A61L31/16; C08H; C08H1/00; C08H1/06; C09; C09J; C09J189/00; C09J189/04; C09J189/06; A61F; A61F2/00; A61F2/02; A61F2/04; A61F2/06; A61F2/07; A61F2002/072; A61F2310/00; A61F2310/00005; A61F2310/00365; A61L2300/00; A61L2300/20; A61L2300/23; A61L2300/236; A61L2300/40; A61L2300/412; A61L2300/414; A61L2430/00; A61L2430/16; C08L2666/00; C08L2666/02
Claims Analysis
Total Claims: 63
Claim 1
Independent Claim
143 words
A collagen-synthetic polymer matrix carrying a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative prepared by a process comprising the steps of: (a) covalently binding collagen with a first multifunctionally activated synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further reacting the covalently binding collagen-synthetic polymer matrix intermediate with a first chemical substance to form a modified collagen-synthetic polymer matrix, wherein the first chemical substance is selected from the group consisting of a second synthetic hydrophilic polymer, a chemical crosslinking agent, an esterifying agent, an amidating agent, an acylating agent, a functionally activated amino acid and a functionally activated peptide; and (c) binding a second chemical substance to the modified covalently binding collagen-synthetic polymer matrix, wherein the second chemical substance is selected from the group consisting of a biologically active agent, a glycosaminoglycan and a glycosaminoglycan derivative.
Claim 2
Dependent Claim
143 words
A collagen-synthetic polymer matrix carrying a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative prepared by a process comprising the steps of: (a) covalently binding collagen with a first multifunctionally activated synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further reacting the covalently binding collagen-synthetic polymer matrix intermediate with a first chemical substance to form a modified collagen-synthetic polymer matrix, wherein the first chemical substance is selected from the group consisting of a second synthetic hydrophilic polymer, a chemical crosslinking agent, an esterifying agent, an amidating agent, an acylating agent, a functionally activated amino acid and a functionally activated peptide; and (c) binding a second chemical substance to the modified covalently binding collagen-synthetic polymer matrix, wherein the second chemical substance is selected from the group consisting of a biologically active agent, a glycosaminoglycan and a glycosaminoglycan derivative.
Claim 3
Dependent Claim
110 words
A collagen-synthetic polymer matrix prepared by a process comprising the steps of: (a) covalently binding collagen with a first multifunctionally activated crosslinking agent consisting of a synthetic hydrophilic polymer covalently binding to form a collagen-synthetic polymer matrix intermediate; (b) further crosslinking the covalently binding collagen-synthetic polymer matrix intermediate with a second multifunctionally activated crosslinking agent to form a modified covalently binding collagen-synthetic polymer matrix, wherein the second multifunctionally activated crosslinking agent is selected from the group consisting of a second synthetic hydrophilic polymer and a chemical crosslinking agent; and (c) binding a biologically active agent to the second multifunctionally activated crosslinking agent in the modified covalently binding collagen-synthetic polymer matrix.
Claim 4
Dependent Claim
110 words
A collagen-synthetic polymer matrix prepared by a process comprising the steps of: (a) covalently binding collagen with a first multifunctionally activated crosslinking agent consisting of a synthetic hydrophilic polymer covalently binding to form a collagen-synthetic polymer matrix intermediate; (b) further crosslinking the covalently binding collagen-synthetic polymer matrix intermediate with a second multifunctionally activated crosslinking agent to form a modified covalently binding collagen-synthetic polymer matrix, wherein the second multifunctionally activated crosslinking agent is selected from the group consisting of a second synthetic hydrophilic polymer and a chemical crosslinking agent; and (c) binding a biologically active agent to the second multifunctionally activated crosslinking agent in the modified covalently binding collagen-synthetic polymer matrix.
Claim 5
Dependent Claim
101 words
A collagen-synthetic polymer matrix carrying a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative prepared by a process comprising the steps of: (a) covalently binding reacting collagen with a first multifunctionally activated synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further reacting the covalently binding collagen-synthetic polymer matrix intermediate with a second synthetic hydrophilic polymer to form a modified covalently binding collagen-synthetic polymer matrix; and (c) binding a substance to the modified collagen-synthetic polymer matrix, wherein the substance is selected from the group consisting of a biologically active agent, a glycosaminoglycan and a glycosaminoglycan derivative.
Claim 6
Dependent Claim
101 words
A collagen-synthetic polymer matrix carrying a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative prepared by a process comprising the steps of: (a) covalently binding reacting collagen with a first multifunctionally activated synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further reacting the covalently binding collagen-synthetic polymer matrix intermediate with a second synthetic hydrophilic polymer to form a modified covalently binding collagen-synthetic polymer matrix; and (c) binding a substance to the modified collagen-synthetic polymer matrix, wherein the substance is selected from the group consisting of a biologically active agent, a glycosaminoglycan and a glycosaminoglycan derivative.
Claim 7
Dependent Claim
19 words
The collagen-synthetic polymer matrix of any one of claims 1 to 3, wherein the collagen is atelopeptide fibrillar collagen.
Claim 8
Dependent Claim
25 words
The collagen-synthetic polymer matrix of claim 4, wherein the first synthetic hydrophilic polymer and/or the second synthetic hydrophilic polymer is a functionally activated polymeric glycol.
Claim 9
Dependent Claim
19 words
The collagen-synthetic polymer matrix of claim 5, wherein the functionally activated polymeric glycol is a difunctionally activated polyethylene glycol.
Claim 10
Dependent Claim
44 words
The collagen-synthetic polymer matrix of claim 3, wherein the collagen and the first and/or the second synthetic hydrophilic polymer are covalently bound to each other by a linkage selected from the group consisting of an ether linkage, an ester linkage, and a urethane linkage.
Claim 11
Dependent Claim
18 words
The collagen-synthetic polymer matrix of claim 1, wherein the first chemical substance is a second synthetic hydrophilic polymer.
Claim 12
Dependent Claim
31 words
The collagen-synthetic polymer matrix of claim 8, wherein the second synthetic hydrophilic polymer is selected from the group consisting of a difunctionally activated polymeric glycol and a monofunctionally activated polyethylene glycol.
Claim 13
Dependent Claim
17 words
The collagen-synthetic polymer matrix of claim 2, wherein the second chemical substance is a biologically active agent.
Claim 14
Dependent Claim
20 words
The modified collagen-synthetic polymer matrix of claim 3, wherein the second chemical substance is a glycosaminoglycan or a glycosaminoglycan derivative.
Claim 15
Dependent Claim
17 words
The collagen-synthetic polymer matrix of claim 1, wherein the second chemical substance is a biologically active agent.
Claim 16
Dependent Claim
35 words
The collagen-synthetic polymer matrix of claim 12, wherein the biologically active agent is selected from the group consisting of a growth factor, a cytokine, an antibiotic, an antiinflammatory agent, an antithrombotic agent and a peptide.
Claim 17
Dependent Claim
19 words
The collagen-synthetic polymer matrix of claim 1, wherein the second chemical substance is a glycosaminoglycan or a glycosaminoglycan derivative.
Claim 18
Dependent Claim
38 words
The collagen-synthetic polymer matrix of claim 14, wherein the second chemical substance is a glycosaminoglycan selected from the group consisting of hyaluronic acid, chondroitin sulfate A, chondroitin sulfate C, dermatan sulfate, keratan sulfate, keratosulfate, chitin, chitosan and heparin.
Claim 19
Dependent Claim
17 words
The collagen-synthetic polymer matrix of claim 1, wherein the first chemical substance is a chemical crosslinking agent.
Claim 20
Dependent Claim
30 words
The collagen-synthetic polymer matrix of claim 16, wherein the chemical crosslinking agent is selected from the group consisting of glutaraldehyde, formaldehyde, divinyl sulfone, a carbodiimide, an epoxide and an imidazole.
Claim 21
Dependent Claim
16 words
The collagen-synthetic polymer matrix of claim 1, wherein the first chemical substance is an esterifying agent.
Claim 22
Dependent Claim
23 words
The collagen-synthetic polymer matrix of claim 18, wherein the esterifying agent is selected from the group consisting of methanol, ethanol, propanol and butanol.
Claim 23
Dependent Claim
16 words
The collagen-synthetic polymer matrix of claim 1, wherein the first chemical substance is an amidating agent.
Claim 24
Dependent Claim
23 words
The collagen-synthetic polymer matrix of claim 20, wherein the amidating agent is selected from the group consisting of glutaric anhydride and succinic anhydride.
Claim 25
Dependent Claim
16 words
The collagen-synthetic polymer matrix of claim 1, wherein the first chemical substance is an acylating agent.
Claim 26
Dependent Claim
21 words
The collagen-synthetic polymer matrix of claim 22, wherein the acylating agent is selected from the group consisting of benzoylchloride and butyrylchloride.
Claim 27
Dependent Claim
45 words
The collagen-synthetic polymer matrix of claim 3, wherein the collagen and the first synthetic hydrophilic polymer are covalently bound to each other by an ether linkage, and the collagen and the second synthetic hydrophilic polymer are covalently bound to each other by an ester linkage.
Claim 28
Dependent Claim
146 words
A process for preparing a collagen-synthetic polymer matrix carrying a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative comprising the steps of: (a) covalently binding reacting collagen with a first multifunctionally activated synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further reacting the covalently binding collagen-synthetic polymer matrix intermediate with a first chemical substance to form a modified covalently binding collagen-synthetic polymer matrix, wherein the first chemical substance is selected from the group consisting of a second synthetic hydrophilic polymer, a chemical crosslinking agent, an esterifying agent, an amidating agent, an acylating agent, a functionally activated amino acid and a functionally activated peptide; and (c) binding a second chemical substance to the modified covalently binding collagen-synthetic polymer matrix, wherein the second chemical substance is selected from the group consisting of a biologically active agent, a glycosaminoglycan and a glycosaminoglycan derivative.
Claim 29
Dependent Claim
146 words
A process for preparing a collagen-synthetic polymer matrix carrying a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative comprising the steps of: (a) covalently binding reacting collagen with a first multifunctionally activated synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further reacting the covalently binding collagen-synthetic polymer matrix intermediate with a first chemical substance to form a modified covalently binding collagen-synthetic polymer matrix, wherein the first chemical substance is selected from the group consisting of a second synthetic hydrophilic polymer, a chemical crosslinking agent, an esterifying agent, an amidating agent, an acylating agent, a functionally activated amino acid and a functionally activated peptide; and (c) binding a second chemical substance to the modified covalently binding collagen-synthetic polymer matrix, wherein the second chemical substance is selected from the group consisting of a biologically active agent, a glycosaminoglycan and a glycosaminoglycan derivative.
Claim 30
Dependent Claim
117 words
A process for preparing a collagen-synthetic polymer matrix comprising the steps of: (a) covalently binding reacting collagen with a first multifunctionally activated crosslinking agent consisting of a synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further crosslinking the covalently binding collagen-synthetic polymer matrix intermediate with a second multifunctionally activated crosslinking agent to form a modified covalently binding collagen-synthetic polymer matrix, wherein the second multifunctionally activated crosslinking agent is selected from the group consisting of a second synthetic hydrophilic polymer and a chemical crosslinking agent; and (c) binding a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative to the second multifunctionally activated crosslinking agent in the modified covalently binding collagen-synthetic polymer matrix.
Claim 31
Dependent Claim
117 words
A process for preparing a collagen-synthetic polymer matrix comprising the steps of: (a) covalently binding reacting collagen with a first multifunctionally activated crosslinking agent consisting of a synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further crosslinking the covalently binding collagen-synthetic polymer matrix intermediate with a second multifunctionally activated crosslinking agent to form a modified covalently binding collagen-synthetic polymer matrix, wherein the second multifunctionally activated crosslinking agent is selected from the group consisting of a second synthetic hydrophilic polymer and a chemical crosslinking agent; and (c) binding a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative to the second multifunctionally activated crosslinking agent in the modified covalently binding collagen-synthetic polymer matrix.
Claim 32
Dependent Claim
19 words
The process of claim 26, wherein a biologically active agent is bound to the second multifunctionally activated crosslinking agent.
Claim 33
Dependent Claim
21 words
The process of claim 26, wherein a glycosaminoglycan or a glycosaminoglycan derivative is bound to the second multifunctionally activated crosslinking agent.
Claim 34
Dependent Claim
88 words
A process for preparing a collagen-synthetic polymer matrix carrying a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative comprising the steps of: (a) covalently binding collagen with a first multifunctionally activated synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further reacting the covalently binding collagen-synthetic polymer matrix intermediate with a second synthetic hydrophilic polymer to form a covalently binding modified collagen-synthetic polymer matrix; and (c) binding a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative to the modified collagen-synthetic polymer matrix.
Claim 35
Dependent Claim
88 words
A process for preparing a collagen-synthetic polymer matrix carrying a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative comprising the steps of: (a) covalently binding collagen with a first multifunctionally activated synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further reacting the covalently binding collagen-synthetic polymer matrix intermediate with a second synthetic hydrophilic polymer to form a covalently binding modified collagen-synthetic polymer matrix; and (c) binding a biologically active agent, a glycosaminoglycan or a glycosaminoglycan derivative to the modified collagen-synthetic polymer matrix.
Claim 36
Dependent Claim
17 words
The process of any one of claims 25 to 29, wherein the collagen is atelopeptide fibrillar collagen.
Claim 37
Dependent Claim
25 words
The process of any one of claims 25 to 29, wherein the first and/or the second synthetic hydrophilic polymer is a functionally activated polymeric glycol.
Claim 38
Dependent Claim
17 words
The process of claim 31, wherein the functionally activated polymeric glycol is a difunctionally activated polyethylene glycol.
Claim 39
Dependent Claim
42 words
The process of claim 29, wherein the collagen and the first and/or the second synthetic hydrophilic polymer are covalently bound to each other by a linkage selected from the group consisting of an ether linkage, an ester linkage and a urethane linkage.
Claim 40
Dependent Claim
16 words
The process of claim 25, wherein the first chemical substance is a second synthetic hydrophilic polymer.
Claim 41
Dependent Claim
29 words
The process of claim 34, wherein the second synthetic hydrophilic polymer is selected from the group consisting of a difunctionally activated polyethylene glycol and a monofunctionally activated polyethylene glycol.
Claim 42
Dependent Claim
15 words
The process of claim 25, wherein the second chemical substance is a biologically active agent.
Claim 43
Dependent Claim
35 words
The process of claim 27 or 36, wherein the biologically active agent is selected from the group consisting of a growth factor, a cytokine, an antibiotic, an antiinflammatory agent, an antithrombotic agent and a peptide.
Claim 44
Dependent Claim
17 words
The process of claim 25, wherein the second chemical substance is a glycosaminoglycan or a glycosaminoglycan derivative.
Claim 45
Dependent Claim
36 words
The process of claim 25, wherein the second chemical substance is a glycosaminoglycan selected from the group consisting of hyaluronic acid, chondroitin sulfate A, chondroitin sulfate C, dermatan sulfate, keratan sulfate, keratosulfate, chitin, chitosan and heparin.
Claim 46
Dependent Claim
15 words
The process of claim 25, wherein the first chemical substance is a chemical crosslinking agent.
Claim 47
Dependent Claim
28 words
The process of claim 40, wherein the chemical crosslinking agent is selected from the group consisting of glutaraldehyde, formaldehyde, divinyl sulfone, a carbodiimide, an epoxide and an imidazolo.
Claim 48
Dependent Claim
14 words
The process of claim 25, wherein the first chemical substance is an esterifying agent.
Claim 49
Dependent Claim
21 words
The process of claim 42, wherein the esterifying agent is selected from the group consisting of methanol, ethanol, propanol and butanol.
Claim 50
Dependent Claim
14 words
The process of claim 25, wherein the first chemical substance is an amidating agent.
Claim 51
Dependent Claim
21 words
The process of claim 44, wherein the amidating agent is selected from the group consisting of glutaric anhydride and succinic anhydride.
Claim 52
Dependent Claim
14 words
The process of claim 25, wherein the first chemical substance is an acylating agent.
Claim 53
Dependent Claim
19 words
The process of claim 46, wherein the acylating agent is selected from the group consisting of benzoylchloride and butyrylchloride.
Claim 54
Dependent Claim
43 words
The process of claim 29, wherein the collagen and the first synthetic hydrophilic polymer are covalently bound to each other by an ether linkage, and the collagen and the second synthetic hydrophilic polymer are covalently bound to each other by an ester linkage.
Claim 55
Dependent Claim
137 words
An implant coating comprising a collagen-synthetic polymer matrix prepared by a process comprising the steps of: (a) covalently binding collagen with a first multifunctionally activated synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further reacting the covalently binding collagen-synthetic polymer matrix intermediate with a first chemical substance to form a modified covalently binding collagen-synthetic polymer matrix, wherein the chemical substance is selected from the group consisting of a second synthetic hydrophilic polymer, a chemical crosslinking agent, an esterifying agent, an amidating agent, an acylating agent, a functionally activated amino acid and a functionally activated peptide; and (c) binding a second chemical substance to the modified covalently binding collagen-synthetic polymer matrix, wherein the second chemical substance is selected from the group consisting of a biologically active agent, a glycosaminoglycan and a glycosaminoglycan derivative.
Claim 56
Dependent Claim
137 words
An implant coating comprising a collagen-synthetic polymer matrix prepared by a process comprising the steps of: (a) covalently binding collagen with a first multifunctionally activated synthetic hydrophilic polymer to form a covalently binding collagen-synthetic polymer matrix intermediate; (b) further reacting the covalently binding collagen-synthetic polymer matrix intermediate with a first chemical substance to form a modified covalently binding collagen-synthetic polymer matrix, wherein the chemical substance is selected from the group consisting of a second synthetic hydrophilic polymer, a chemical crosslinking agent, an esterifying agent, an amidating agent, an acylating agent, a functionally activated amino acid and a functionally activated peptide; and (c) binding a second chemical substance to the modified covalently binding collagen-synthetic polymer matrix, wherein the second chemical substance is selected from the group consisting of a biologically active agent, a glycosaminoglycan and a glycosaminoglycan derivative.
Claim 57
Dependent Claim
16 words
The implant coating of claim 49, wherein the second chemical substance is a biologically active agent.
Claim 58
Dependent Claim
17 words
The implant coating of claim 50, wherein the first chemical substance is a second synthetic hydrophilic polymer.
Claim 59
Dependent Claim
17 words
The implant coating of claim 49, wherein the first chemical substance is a second synthetic hydrophilic polymer.
Claim 60
Dependent Claim
18 words
The implant coating of claim 49, wherein the second chemical substance is a glycosaminoglycan or a glycosaminoglycan derivative.
Claim 61
Dependent Claim
40 words
The implant coating of any one of claims 49 to 53; wherein the coating is capable of being used to coat an implant selected from the group consisting of a vascular graft, a vascular stent and a vascular stent-graft combination.
Claim 62
Dependent Claim
55 words
A collagen-synthetic polymer matrix comprising: (a) a multifunctionally activated synthetic hydrophilic polymer; (b) covalently binding collagen covalently bound to the multifunctionally activated synthetic hydrophilic polymer; and (c) a biologically active agent covalently bound to the multifunctionally activated synthetic hydrophilic polymer; wherein a majority of said biologically active agent is on a surface of the matrix.
Claim 63
Dependent Claim
55 words
A collagen-synthetic polymer matrix comprising: (a) a multifunctionally activated synthetic hydrophilic polymer; (b) covalently binding collagen covalently bound to the multifunctionally activated synthetic hydrophilic polymer; and (c) a biologically active agent covalently bound to the multifunctionally activated synthetic hydrophilic polymer; wherein a majority of said biologically active agent is on a surface of the matrix.
References Cited (Backward Citations)
US3272204A
Cited
US4179337A
Cited
US3949073A
Cited
US4488911A
Cited
US4164559A
Cited
US4678468A
Cited
US4557764A
Cited
US4655980A
Cited
US4600533A
Cited
US4689399A
Cited
US4725671A
Cited
US4642117A
Cited
US4980403A
Cited
US5162430A
Cited
US5292802A
Cited
US5141747A
Cited
JPH04227265A
Cited
WO1994003155A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-08-31 | 2002-03-02 | 2002-09-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-08-31 | 2006-03-02 | 2006-09-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-08-31 | 2010-03-02 | 2010-09-01 | $7700.00 | Window Closed / Lapsed |